(Q46615751)

23 December 2017

title

Effects of cannabinoid receptor agonist WIN 55,212-2 on blood-brain barrier disruption in focal cerebral ischemia in rats (English)

1 reference

23 December 2017

0 references

0 references

0 references

1 reference

1 reference

Oak Z Chi

1

1 reference

23 December 2017

Sylviana Barsoum

2

1 reference

23 December 2017

Jeremy Grayson

3

1 reference

23 December 2017

Christine Hunter

4

1 reference

23 December 2017

Xia Liu

5

1 reference

23 December 2017

Harvey R Weiss

6

1 reference

23 December 2017

publication date

1 January 2012

1 reference

23 December 2017

published in

Pharmacology

1 reference

23 December 2017

volume

89

1 reference

23 December 2017

issue

5-6

1 reference

23 December 2017

page(s)

333-338

1 reference

23 December 2017

Effect of transient focal ischemia on blood-brain barrier permeability in the rat: correlation to cell injury.

cites work

1 reference

Effects of GABA(A) receptor blockade on regional cerebral blood flow and blood-brain barrier disruption in focal cerebral ischemia

21 January 2018

1 reference

Capillary NMDA receptors regulate blood-brain barrier function and breakdown

21 January 2018

1 reference

Effects of inhibition of nitric oxide synthase on blood-brain barrier transport in focal cerebral ischemia

21 January 2018

1 reference

Glutamate-induced disruption of the blood-brain barrier in rats. Role of nitric oxide.

21 January 2018

1 reference

Protective effect of flunarizine on blood-brain barrier permeability alterations in acutely hypertensive rats

21 January 2018

1 reference

Cannabinoid physiology and pharmacology: 30 years of progress.

21 January 2018

1 reference

Cannabinoid receptors as therapeutic targets.

21 January 2018

1 reference

Modulation of the balance between cannabinoid CB(1) and CB(2) receptor activation during cerebral ischemic/reperfusion injury

21 January 2018

1 reference

Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity

21 January 2018

1 reference

Modulation of NMDA and AMPA-mediated synaptic transmission by CB1 receptors in frontal cortical pyramidal cells

21 January 2018

1 reference

Glutamate causes a loss in human cerebral endothelial barrier integrity through activation of NMDA receptor

21 January 2018

1 reference

Metabotropic and NMDA glutamate receptors participate in the cannabinoid-induced antinociception

21 January 2018

1 reference

Evidences of cannabinoids-induced modulation of paroxysmal events in an experimental model of partial epilepsy in the rat.

21 January 2018

1 reference

Role of cannabinoids and endocannabinoids in cerebral ischemia

21 January 2018

1 reference

The microcirculation of rat circumventricular organs and pituitary gland.

21 January 2018

1 reference

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

21 January 2018

1 reference

Blockade of cannabinoid CB(1) receptor function protects against in vivo disseminating brain damage following NMDA-induced excitotoxicity.

21 January 2018

1 reference

Rimonabant attenuates sensitization, cross-sensitization and cross-reinstatement of place preference induced by nicotine and ethanol

21 January 2018

1 reference

Antagonism of ∆⁹-THC induced behavioral effects by rimonabant: time course studies in rats

21 January 2018

1 reference

Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide

21 January 2018

1 reference

Cannabinoid modulation of electrically evoked pH and oxygen transients in the nucleus accumbens of awake rats.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000338755

1 reference

23 December 2017

1 reference

23 December 2017